Skip to main content
Health & Medicine

Paleogenomics illuminates mobility and changing lifeways in Chalcolithic Anatolia.

| Source: Cell

Once labeled the "Dark Ages" of Anatolian prehistory, the Chalcolithic period (c. 6000-3000 BCE) was characterized by drastically reduced settlement densities compared with the preceding Neolithic and the succeeding Bronze Ages, a change interpreted as population decline. Using 44 new genomes combined with published data, we find no evidence for a population reduction. The genetic evidence instead suggests that populations in Chalcolithic Anatolia were increasingly mobile and/or growing in size

Once labeled the "Dark Ages" of Anatolian prehistory, the Chalcolithic period (c. 6000-3000 BCE) was characterized by drastically reduced settlement densities compared with the preceding Neolithic and the succeeding Bronze Ages, a change interpreted as population decline. Using 44 new genomes combined with published data, we find no evidence for a population reduction. The genetic evidence instead suggests that populations in Chalcolithic Anatolia were increasingly mobile and/or growing in size while receiving gene flow from eastern regions (e.g., East Anatolia and the South Caucasus) through a 3,000-year-long admixture process. We propose that genetic and archaeological evidence may be reconciled by hypothesizing the presence of communities with dispersed and mobile lifeways that are mostly invisible to archaeology. These communities also practiced consanguinity at frequencies unobserved in previous periods. Finally, we identify a mid-5th-millennium BCE individual in Central Anatolia carrying ∼10%-30% Pontic-Caspian Steppe-related ancestry, shedding light on mobility between the Eurasian Steppe and Anatolia.

Read the original source →

Related Stories

Health & Medicine

Distinct nanoscale architectures of GABAergic inhibitory synapses predict diverse synaptic output.

GABAergic synaptic inhibition is heterogenous across neuronal compartments, and plays a critical role in shaping local, cellular, and circuit excitability. In pyramidal neurons, inhibition is mediated by GABA A receptors (GABA A Rs) clustered at the inhibitory postsynaptic domain (iPSD). Synaptic strength depends not only on the number of GABA A Rs within the iPSD, but also on their precise nanoscale organization into discrete subsynaptic domains (SSDs). These SSDs often align with presynaptic G

Continue reading
Health & Medicine

Leptin Receptor + cells create a perisinusoidal niche for thrombopoiesis in the bone marrow by synthesizing CXCL14.

Leptin Receptor-expressing (LepR + ) stromal cells in the bone marrow are a critical source of growth factors for the maintenance of hematopoietic stem cells (HSCs) and most restricted hematopoietic progenitors. An important unresolved question is whether they also regulate terminal differentiation in some hematopoietic cells. We found that bone marrow LepR + cells promote thrombopoiesis by synthesizing the chemokine CXCL14. Cxcl14 -expressing LepR + cells extend fine processes that wrap around

Continue reading
Health & Medicine

SCN1B intron 3 retention results in a nonsense-mediated decay-sensitive mRNA linked to developmental and epileptic encephalopathy.

Biallelic variants in the voltage-gated sodium channel (VGSC) gene SCN1B are linked to developmental and epileptic encephalopathy type 52 (DEE52). SCN1B encodes two isoforms: transmembrane β1, generated by all 6 coding exons, and β1B, generated by exons 1 to 3 followed by retention of intron 3 ( SCN1B -IR). Transmembrane β1 subunits are multifunctional proteins that regulate sodium current and channel cell-surface expression, participate in cell-cell and cell-matrix adhesion, a

Continue reading
Health & Medicine

Anomeric configuration encodes mesophase preference of glucosylceramides in phospholipid membranes.

Glycosphingolipids are key components of the cell glycocalyx, yet the extent to which their anomeric configuration affects their membrane organization remains unclear. Glucosylceramide (GlcCer) exists as α- and β-anomers with distinct biological activities, while the biophysical basis for these differences is unknown. Here, using nitroxide spin-labeled analogs of α- and β-GlcCer, we examined how the glycosidic stereochemistry affects their partitioning in phospholipid bil

Continue reading
Health & Medicine

A genome-wide senescence synthetic lethality screen identifies PARP16 as a senolytic target.

Accumulation of senescent cells is increasingly viewed as a significant contributor to aging and age-related diseases. To date, the elimination of senescent cells through small molecule senolytic agents has largely relied on a limited number of repurposed agents, often leveraged from previous oncological applications. Here, we describe a CRISPR-based, genome-wide, synthetic lethal screen for senescent cells. From this screen, we identify a number of genes whose deletion appears to be well tolera

Continue reading